false
Catalog
Reviewing Treatment Options for Cardiac Amyloidosi ...
3. Reviewing Treatment Options for Cardiac Amyloid ...
3. Reviewing Treatment Options for Cardiac Amyloidosis with the CV Care Team
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The discussion on cardiac amyloidosis explored the condition's pathology, diagnosis, and treatment. Cardiac amyloidosis is characterized by protein deposits in the heart, causing thickening and stiffening, ultimately leading to heart failure symptoms. Diagnosis requires identifying protein origins (AL amyloidosis from immunoglobulin light chains and TTR amyloidosis from the transthyratin protein) through specific lab tests. Treatment involves collaboration between cardiologists and hematologists, particularly for TTR forms, using stabilizers to prevent protein degradation and potential new therapies like vutricerin. Nurse practitioners, like Janelle Grazzini-France, play a crucial role in patient education and follow-up care, while pharmacists, like Dan Landup, assist in managing drug interactions and navigating prescription processes. The evolving therapeutic landscape, including drugs like tefamidus and acaramidus, alongside potential new treatments, represents hope despite challenges in managing this complex disease.
Keywords
cardiac amyloidosis
restrictive cardiomyopathy
immunoglobulin light chains
transthyretin protein
heart failure symptoms
protein deposits
diagnosis
treatment
therapeutic landscape
×
Please select your language
1
English